Treatment Overview
Photodynamic therapy (PDT) is a treatment for
wet
age-related macular degeneration (wet AMD). It is not used to treat
dry
AMD.
In photodynamic therapy, a light-sensitive medicine called
verteporfin (Visudyne) is injected into the bloodstream. The medicine collects
in the abnormal blood vessels under the macula. Laser light is then shone into
the eye, which activates the medicine and causes it to create blood clots that
block the abnormal blood vessels.
By sealing the leaky blood vessels, photodynamic therapy slows
down:
- The buildup of fluid under the retina that
distorts the shape and position of the macula.
- The growth of scar
tissue and the abnormal membrane under the retina, both of which damage the
cells in the macula.
- Central vision loss.
Photodynamic therapy takes about 20 minutes and may be done in a
doctor's office or eye clinic.
What To Expect After Treatment
The verteporfin medicine used in PDT makes your skin and eyes more
sensitive to light. After treatment, you should avoid direct sunlight for 2 to
5 days and, when outdoors, wear special dark sunglasses to protect your
eyes.
Your doctor will want you to return for a follow-up exam about a
month after treatment.
Why It Is Done
Photodynamic therapy is used to treat
wet
age-related macular degeneration (AMD) only. PDT can only be used for a
minority of cases as well.1
By limiting the growth of abnormal blood vessels under the macula,
photodynamic therapy may help prevent the progression of wet AMD. It does not
restore vision to eyes that have already been damaged, but it may help prevent
further damage to the retina and further vision loss. People with wet AMD often
need multiple treatments to get the full benefits of the therapy.
Some experts think that photodynamic therapy may be more effective
and less destructive than laser surgery. Laser treatment almost always causes
some immediate, permanent central vision loss (a central blind spot), and it
does not always prevent future growth of abnormal blood vessels. Photodynamic
therapy may be better able to target the blood vessels without damaging the
nerve cells in the retina and macula.
How Well It Works
PDT can lower the risk of severe vision loss by reducing the growth
of and leakage from abnormal blood vessels under the retina.2 How well the treatment works depends on where and how the
abnormal blood vessels are growing beneath the retina. For some types of wet
AMD, the treatment has no detectable benefit.
The effect of PDT in slowing the progress of AMD is often
temporary, and the abnormal blood vessels begin leaking again after about 3
months. Most people need multiple treatments to get the full benefits of the
therapy.
Risks
A severe loss in visual clarity occurs in 1% to 4% of people
treated with PDT. In some cases, vision partially recovers.3
Other side effects that may occur with PDT include:
- Temporary visual disturbances (abnormal vision,
decreased vision, defects in the visual field).
- Pain, swelling,
bleeding, or inflammation at the site where the verteporfin medicine is
injected. Some people also experience low back pain related to the injection of
the medicine.
- Photosensitivity reactions (such as sunburn).
What To Think About
Photodynamic therapy (PDT) has been shown to be effective for only
certain types of wet AMD. The treatment may not work for you.
The effectiveness and long-term consequences of PDT are still
being studied.
The verteporfin (Visudyne) dye is an expensive medicine, adding to
the overall cost of the treatment. But you must balance this cost against the
potential benefit it provides in slowing or reducing the loss of vision from
AMD.
Complete the
special treatment information form (PDF)
(What is a PDF document?)
to help you understand this treatment.